Efficacy and safety of Apo866 in patients with refractory or relapsed cutaneous t-cell lymphoma: a phase 2 clinical trial

Goldinger, Simone M; Gobbi Bischof, Sharon; Fink-Puches, Regina; Klemke, Claus-Detlev; Dréno, Brigitte; Bagot, Martine; Dummer, Reinhard (2016). Efficacy and safety of Apo866 in patients with refractory or relapsed cutaneous t-cell lymphoma: a phase 2 clinical trial. JAMA Dermatology, 152(7):837-839.

Additional indexing

Item Type:	Journal Article, refereed, further contribution
Communities & Collections:	04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
Dewey Decimal Classification:	610 Medicine & health
Scopus Subject Areas:	Health Sciences > Dermatology
Language:	English
Date:	23 March 2016
Deposited On:	14 Apr 2016 17:56
Last Modified:	15 Jan 2025 02:37
Publisher:	American Medical Association (AMA)
ISSN:	2168-6068
OA Status:	Closed
Publisher DOI:	https://doi.org/10.1001/jamadermatol.2016.0401
PubMed ID:	27007550